[DOI] [PubMed] [Google Scholar] 185.Han MS, Jung DY, Morel C, Lakhani SA, Kim JK, Flavell RA, et al
These findings support a personalised approach, where absorption efficiency may be more relevant than absolute dosage
That wider catalog is one of the reasons Swisschems gained traction among users who prefer sourcing multiple compounds from a single supplier
Disclosure of interest: Name of author: nothing to disclose Poster session I - DIAGNOSIS / ETIOLOGY 04.00 - DIAGNOSIS / ETIOLOGY - 04.10 - ESUS/CRYPTOGENIC STROKE P330 - ESOC25-180 LEFT VENTRICULAR DISEASE AS A RISK FACTOR FOR ADVERSE OUTCOMES AND STROKE RECURRENCE IN PATIENTS WITH EMBOLIC STROKE OF UNDETERMINED SOURCE Angelo Cascio Rizzo 1 , Ghil Schwarz, Andrea Bonelli 1 , Andrea Magi 2 , Elio Agostoni 1 , Antonella Moreo 1 , Maria Sessa 1 ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy, 2 University of Milano-Bicocca, Milan, Italy Background and Aims: LV disease (LVD), such as mild-to-moderate LV dysfunction and LV wall-motion-abnormalities (LVWMA), are considered potential minor cardiac sources in ESUS, but their role is underexplored
It supports healthy cell reproduction, protein synthesis, and blood formation
As a result, BPC-157 and TB-500 are frequently discussed in research exploring muscle, tendon, and connective tissue biology
